Trials Sponsors Conditions Drugs Pricing

Conditions

Acute Coronary Syndrome Acute Pulmonary Edema Arrhythmias, Cardiac Heart Failure

Keywords

acute coronary syndromestatinacute pulmonary edemamalignant arrhythmiaheart failure

Outcome Measures

Primary Outcomes (3)

Heart Failure
Based on echocardiographic findings from the medical records
Through study completion, an average of 1 year
Malignant Arrhythmia
Presence of ventricular tachycardia (VT) or ventricular fibrillation (VF)
Through study completion, an average of 1 year
Acute Lung Edema
Based on medical records or reported clinical findings of lung edema - rhonchi reported in 1/3 of the lungs with oxygen saturation \<90%.
Through study completion, an average of 1 year

Study Arms (2)

Statin

History of statin use prior to Acute Coronary Syndrome

Drug: Statins (Cardiovascular Agents)

Non-Statin

No documented history of statin use prior to Acute Coronary Syndrome

Interventions

Statins (Cardiovascular Agents)Drug

Prescribed with statins

Statin

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Adult patients (≥ 18 years of age) with acute coronary syndrome which are diagnosed under ICD-10 coding of I24.9 without a prior history of heart failure, acute lung edema and arrhythmia.

You may qualify if:

Clinical diagnosis of Acute Coronary Syndrome

Sponsors & Collaborators

Cengkareng General Hospital
Othercollaborator
Tarumanagara University
Otherlead

Study Sites (1)

Cengkareng General Hospital

Jakarta, DKI Jakarta, Indonesia

MeSH Terms

Conditions

Acute Coronary SyndromeArrhythmias, CardiacHeart Failure

Interventions

Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular Agents

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anticholesteremic Agents

Study Officials

Andria Priyana, MD, FIHA
Department of Cardiology, Faculty of Medicine, Tarumanagara University
STUDY CHAIR
Angela F Sunjaya
Tarumanagara University
PRINCIPAL INVESTIGATOR
Anthony P Sunjaya
Tarumanagara University
PRINCIPAL INVESTIGATOR

Enrollment

130 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Co Principal Investigator

Study Record Dates

First Submitted

July 12, 2018

First Posted

July 24, 2018

Study Start

August 1, 2017

Actual (reported)

Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (3)

Study Arms (2)

Statin

Non-Statin

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (3)

Study Arms (2)

Statin

Non-Statin

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations